特殊成分
Urolithin A Powder | Bulk Urolithin A Supplier
Urolithin A powder for supplement and functional nutrition product development, with product specifications and batch documentation available to support material review.
Product Specifications
Urolithin A Product Profile
Key information for confirming the material before reviewing the full analytical specification.
Ingredient Overview
A Defined Urolithin A Ingredient
Urolithin A is a defined small-molecule metabolite associated with the metabolism of ellagitannins and ellagic acid. As a finished ingredient, it is evaluated as a specific compound rather than as a general botanical extract.
Formulation Context
Urolithin A has attracted attention in specialty nutrition products, particularly in areas connected with mitochondrial and muscle-related research.
Material Review
For product development, the important considerations are the stated specification, analytical results and the suitability of the powder for the intended formulation.
技術仕様
Urolithin A Specification & COA Results
Specification limits, test methods and results recorded on the supplied Certificate of Analysis.
| Test Item | 仕様 | 方法 | Result |
|---|---|---|---|
| Physical & Purity | |||
| 外観 | White to Light yellow powder | ビジュアル | Light yellow powder |
| 純度 | ≥97% | HPLC | 99.45% |
| 水 | ≤3% | GB5009.3 | 0.21% |
| Single Impurity | ≤1.0% | HPLC | 0.35% |
| Organic Solvent | ≤3000 ppm | GC | N/D |
| 重金属 | |||
| Lead (Pb) | ≤0.5 ppm | GB5009.12 | Conform |
| 水銀（Hg） | ≤0.5 ppm | GB5009.17 | Conform |
| Cadmium (Cd) | ≤0.5 ppm | GB5009.15 | Conform |
| Arsenic (As) | ≤0.5 ppm | GB5009.11 | Conform |
| Microbiological Controls | |||
| Total Microbial Count | ≤500 CFU/g | GB4789.2 | <10 |
| Coliform | ≤0.92 MPN/g | GB4789.3 | Conform |
| Mold and Yeast | ≤50 CFU/g | GB4789.15 | Conform |
| 黄色ブドウ球菌 | 0/25 g | GB4789.10 | Conform |
| Anisidine Value | 0/25 g | GB4789.4 | Conform |
| 溶解度 | |||
| 溶解度 | As stated on COA | COA | Soluble in DMSO; slightly soluble in methanol and ethanol |
COA Batch
Batch Information
Batch details corresponding to the Certificate of Analysis presented above.
アプリケーション
Urolithin A Powder in Product Development
The powder can be evaluated in different finished-product formats, depending on formulation and manufacturing requirements.
カプセル
Suitable for capsule formulations where the material properties and target active loading fit the product design.
タブレット
Can be evaluated for tablet development according to blending, flow and processing requirements.
Powder Formulations
Can be considered for powdered products where the physical profile works with the intended formulation process.
Functional Food Formats
Urolithin A has also been evaluated in selected food formats, subject to the requirements of the destination market.
Raw Material Qualification
Before Approval
A practical review should connect the required specification with the sample and the batch intended for production.
Key Review Points
Production Route
The supplied Certificate of Analysis does not state the production route. Where production route is part of the approved specification, confirm it in the applicable technical documentation.
Regulatory Note
Destination-Market Requirements
Regulatory requirements depend on the intended use and destination market.
米国
FDA GRAS Notice 791 records an FDA “no questions” response for Urolithin A under the conditions of use described in the notification.
United Kingdom
The UK Food Standards Agency currently lists RP-1777 for Urolithin A as a novel food application with risk assessment in progress.
ストレージ
Storage & Shelf Life
Storage information follows the supplied Certificate of Analysis.
Storage Condition
Keep in a cool and dry place. Keep away from strong light and heat.
賞味期限
The supplied Certificate of Analysis states a shelf life of 2 years.
Request Urolithin A Pricing & Product Information
Tell us your required quantity, formulation format, destination market and specification requirements for a product review and quotation.